Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer

Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes

(2013) Vakkat Muraleedharan et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial

(2013) E. Del Fabbro et al.   SUPPORTIVE CARE IN CANCER

Low Testosterone Levels and Increased Inflammatory Markers in Patients with Cancer and Relationship with Cachexia

(2012) Basil O. Burney et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

(2011) Giovanni Corona et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Preliminary Report: Vitamin D Deficiency in Advanced Cancer Patients with Symptoms of Fatigue or Anorexia

(2011) R. Dev et al.   ONCOLOGIST

Associations Among Hypogonadism, C-Reactive Protein, Symptom Burden, and Survival in Male Cancer Patients with Cachexia: A Preliminary Report

(2010) Egidio Del Fabbro et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men

(2009) Åsa Tivesten et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

(2006) T. MULLIGAN et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE